Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY: A )

120.01 +0.63 (+0.53%)
Streaming Delayed Price Updated: 2:24 PM EDT, May 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 785,319
Open 119.63
Bid (Size) 119.98 (1)
Ask (Size) 120.03 (1)
Prev. Close 119.38
Today's Range 118.83 - 121.03
52wk Range 112.64 - 179.57
Shares Outstanding 303,443,225
Dividend Yield 0.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Peering Into Agilent Technologies's Recent Short Interest
Agilent Technologies's (NYSE:A) short percent of float has risen 30.22% since its last report. The company recently reported that it has 5.41 million shares sold short, which is 1... 
Via Benzinga
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
From Agilent Technologies Inc.
Via Business Wire

Performance

YTD
-23.31%
-23.31%
1 Month
-3.09%
-3.09%
3 Month
-11.24%
-11.24%
6 Month
-23.94%
-23.94%
1 Year
-7.76%
-7.76%

More News

Read More
If You Invested $1000 In Agilent Technologies 15 Years Ago, Here's How Much You Would Have Today
Via Benzinga
Analyzing Agilent Technologies Inc's Short Interest
Via Benzinga
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
From Agilent Technologies Inc.
Via Business Wire
Analyst Ratings for Agilent Technologies
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
Via Benzinga
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
Via Benzinga
Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
From Agilent Technologies Inc.
Via Business Wire
Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others
Via Investor's Business Daily
Agilent Joins AMBIC to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Analyzing Agilent Technologies Inc's Short Interest
Via Benzinga
20 Dividend Contenders Collapsing As The Bear Growls
Via Talk Markets
Analyzing Agilent Technologies Inc's Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Via Benzinga
Looking Into Agilent Technologies Inc's Recent Short Interest
Via Benzinga
Agilent to Participate at Cowen and Barclays Health Care Conferences
From Agilent Technologies Inc.
Via Business Wire
Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
From Agilent Technologies Inc.
Via Business Wire
Expert Ratings For Agilent Technologies
Via Benzinga
Agilent's Q1 FY22 Earnings Beat Expectations, FY22 Guidance Surpass Street Estimates
Via Benzinga
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
From Agilent Technologies Inc.
Via Business Wire
10 Biggest Price Target Changes For Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.